Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Binding Proteins | 13 | 2019 | 700 | 2.700 |
Why?
|
| DNA Repair | 7 | 2019 | 127 | 1.930 |
Why?
|
| Rad51 Recombinase | 5 | 2016 | 16 | 1.580 |
Why?
|
| DNA Damage | 8 | 2019 | 190 | 1.120 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2019 | 24 | 0.740 |
Why?
|
| Homologous Recombination | 2 | 2017 | 13 | 0.740 |
Why?
|
| Thioguanine | 2 | 2017 | 4 | 0.700 |
Why?
|
| Fibroblasts | 6 | 2019 | 902 | 0.670 |
Why?
|
| Recombinational DNA Repair | 1 | 2019 | 6 | 0.660 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 9 | 0.650 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.630 |
Why?
|
| Mitosis | 1 | 2017 | 76 | 0.580 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 14 | 0.540 |
Why?
|
| Chromosomal Instability | 4 | 2017 | 14 | 0.520 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 89 | 0.520 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 1293 | 0.500 |
Why?
|
| Mice | 14 | 2019 | 8474 | 0.470 |
Why?
|
| Biomedical Research | 1 | 2018 | 310 | 0.470 |
Why?
|
| Animals | 18 | 2019 | 20881 | 0.420 |
Why?
|
| Mitomycin | 4 | 2019 | 27 | 0.380 |
Why?
|
| Cisplatin | 2 | 2009 | 192 | 0.370 |
Why?
|
| Chromatids | 1 | 2010 | 8 | 0.370 |
Why?
|
| Guanine | 1 | 2010 | 21 | 0.350 |
Why?
|
| Cell Cycle | 3 | 2014 | 312 | 0.350 |
Why?
|
| Cross-Linking Reagents | 2 | 2010 | 80 | 0.340 |
Why?
|
| Genes, p53 | 1 | 2009 | 41 | 0.340 |
Why?
|
| Neoplasms | 2 | 2019 | 1667 | 0.330 |
Why?
|
| Cell Line | 4 | 2019 | 1752 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 214 | 0.320 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 215 | 0.320 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 1070 | 0.320 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 271 | 0.310 |
Why?
|
| Genetic Variation | 1 | 2009 | 220 | 0.300 |
Why?
|
| Embryo, Mammalian | 3 | 2019 | 176 | 0.300 |
Why?
|
| DNA | 3 | 2011 | 597 | 0.300 |
Why?
|
| Proteomics | 1 | 2009 | 246 | 0.290 |
Why?
|
| DNA Breaks | 1 | 2006 | 2 | 0.290 |
Why?
|
| Germ Cells | 1 | 2006 | 17 | 0.270 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 83 | 0.260 |
Why?
|
| Protein Binding | 4 | 2016 | 1027 | 0.250 |
Why?
|
| DNA Methylation | 1 | 2006 | 193 | 0.250 |
Why?
|
| Gene Deletion | 3 | 2010 | 235 | 0.230 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 189 | 0.210 |
Why?
|
| Protein Isoforms | 2 | 2016 | 246 | 0.200 |
Why?
|
| Telomere | 2 | 2017 | 59 | 0.200 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 62 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1536 | 0.170 |
Why?
|
| Hygromycin B | 1 | 2019 | 1 | 0.170 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 7 | 0.170 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 7 | 0.160 |
Why?
|
| Methylnitronitrosoguanidine | 2 | 2010 | 8 | 0.160 |
Why?
|
| Mutation | 2 | 2019 | 1213 | 0.160 |
Why?
|
| Blotting, Western | 3 | 2009 | 954 | 0.160 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2009 | 28 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2009 | 36 | 0.150 |
Why?
|
| HeLa Cells | 2 | 2016 | 237 | 0.140 |
Why?
|
| Transfection | 1 | 2019 | 782 | 0.140 |
Why?
|
| Methyl Methanesulfonate | 2 | 2006 | 7 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 55 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 69 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2016 | 85 | 0.130 |
Why?
|
| Drug Discovery | 1 | 2017 | 94 | 0.130 |
Why?
|
| Proteolysis | 1 | 2016 | 97 | 0.130 |
Why?
|
| Colitis | 1 | 2017 | 156 | 0.130 |
Why?
|
| Humans | 10 | 2019 | 68618 | 0.130 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1083 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2016 | 305 | 0.120 |
Why?
|
| Cyclins | 1 | 2014 | 50 | 0.120 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 60 | 0.120 |
Why?
|
| G2 Phase | 2 | 2011 | 26 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 322 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 331 | 0.100 |
Why?
|
| Cell Survival | 2 | 2014 | 901 | 0.100 |
Why?
|
| Peptides | 1 | 2014 | 455 | 0.100 |
Why?
|
| Models, Biological | 2 | 2006 | 981 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2014 | 546 | 0.100 |
Why?
|
| DNA Mismatch Repair | 1 | 2011 | 42 | 0.090 |
Why?
|
| PTB-Associated Splicing Factor | 1 | 2010 | 1 | 0.090 |
Why?
|
| Alkylating Agents | 1 | 2010 | 15 | 0.090 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 32 | 0.090 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2010 | 32 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2550 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 132 | 0.080 |
Why?
|
| DNA Primers | 1 | 2009 | 302 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2009 | 89 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1851 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 188 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 137 | 0.080 |
Why?
|
| Uracil | 1 | 2008 | 18 | 0.080 |
Why?
|
| Neural Crest | 1 | 2008 | 58 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2008 | 81 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 58 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2009 | 362 | 0.070 |
Why?
|
| Base Sequence | 1 | 2009 | 1015 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2008 | 72 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 332 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 306 | 0.070 |
Why?
|
| Meiosis | 1 | 2006 | 5 | 0.070 |
Why?
|
| Mammals | 1 | 2006 | 47 | 0.070 |
Why?
|
| Spermatozoa | 1 | 2006 | 75 | 0.070 |
Why?
|
| Oocytes | 1 | 2006 | 57 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 77 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 191 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2005 | 56 | 0.060 |
Why?
|
| Sister Chromatid Exchange | 1 | 2005 | 7 | 0.060 |
Why?
|
| Centrosome | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 204 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1174 | 0.060 |
Why?
|
| Stem Cells | 1 | 2006 | 248 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 231 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1447 | 0.050 |
Why?
|
| Apoptosis | 1 | 2010 | 1641 | 0.050 |
Why?
|
| Neurons | 1 | 2008 | 881 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1664 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 2791 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 88 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2017 | 215 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 554 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 420 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2014 | 397 | 0.030 |
Why?
|
| Male | 3 | 2017 | 37321 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2008 | 1692 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.020 |
Why?
|
| Giant Cells | 1 | 2011 | 14 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.020 |
Why?
|
| Folic Acid Deficiency | 1 | 2008 | 16 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 337 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 562 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1174 | 0.020 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Spermatocytes | 1 | 2004 | 3 | 0.010 |
Why?
|
| DNA, Cruciform | 1 | 2004 | 2 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 100 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 86 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 144 | 0.010 |
Why?
|
| Chromatin | 1 | 2004 | 76 | 0.010 |
Why?
|
| Female | 1 | 2006 | 38074 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 235 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 434 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 511 | 0.010 |
Why?
|